NORCCAP: Norwegian Colorectal Cancer Prevention Trial

Study acronym: NORCCAP
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Norwegian Department of Health and Social Affairs to Norwegian Institute of Public Health
    • Start date: Jan 1999 to Jan 1, 1999
    v11
  2. 2 versions Re-verified since Sep 6, 2019, no change to tracked fieldsv9-v10
  3. Primary and study completion dates: Dec 2017 to Dec 2036v8
  4. Phase: Phase 2/3 to Not applicable
    • Primary and study completion dates: Mar 2017 to Dec 2017
    • Secondary endpoints: details revised at 2 of 2 entries
    v7
  5. Primary and study completion dates pushed to Mar 2017
    • Interventions: Fecal Occult Blood Test (FOBT) screening (Procedure), Flexible sigmoidoscopy (Procedure) to A 1 Intervention arm Flex Sig (Procedure), A 2 Intervention arm Flex Sig + iFOBT (Procedure)
    • Publications: details revised at 3 of 30 entries
    • Study arms: 2 to 3
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary endpoints: 3 to 1
    • Primary completion date: Mar 2013
    • Publications: details revised at 1 of 30 entries
    • Study description shortened, about 1 word
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Primary endpoints revised (3)v3 Show 5 more changesShow less
    • Study completion date: Jan 2002 to Jan 2017
    • Interventions: Fecal Occult Blood Test (FOBT) screening (Procedure), Flexible sigmoidoscopy screening (Procedure) to Fecal Occult Blood Test (FOBT) screening (Procedure), Flexible sigmoidoscopy (Procedure)
    • Secondary endpoints: details revised at 2 of 2 entries
    • Publications: 12 to 30
    • Study arms: 0 to 2
  4. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The purpose of this study is to see if screening with flexible sigmoidoscopy (a flexible viewing tube) may reduce large bowel cancer and cancer deaths. The researchers also want to see if the addition of screening for occult blood in stools may contribute further to this aim. Additionally, the researchers also want to see to which extent (and in which direction) the study may influence overall endoscopic activity in the general population in the screening area and in areas where controlled screening is not established.
Trial Details
NCT Number NCT00119912
Lead Sponsor Norwegian Institute of Public Health
Collaborators: Norwegian Cancer Society
Conditions
(from sponsor)		 Colorectal Cancer, Adenoma
Related terms Adenoma, Colorectal Neoplasms, Neoplasms
Enrollment 100,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov